MANZARI, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 17.016
AS - Asia 2.184
EU - Europa 2.162
SA - Sud America 290
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 34
OC - Oceania 2
Totale 21.876
Nazione #
US - Stati Uniti d'America 16.909
SG - Singapore 1.199
DE - Germania 619
CN - Cina 376
IT - Italia 371
RU - Federazione Russa 261
BR - Brasile 235
UA - Ucraina 221
IE - Irlanda 178
VN - Vietnam 172
HK - Hong Kong 168
GB - Regno Unito 139
FR - Francia 98
SE - Svezia 71
KR - Corea 60
FI - Finlandia 59
PL - Polonia 54
JP - Giappone 50
CA - Canada 45
BD - Bangladesh 40
IN - India 31
ID - Indonesia 26
BE - Belgio 22
NL - Olanda 21
AR - Argentina 15
CO - Colombia 14
ES - Italia 14
MX - Messico 11
ZA - Sudafrica 11
EC - Ecuador 10
HN - Honduras 10
TR - Turchia 9
CL - Cile 7
CZ - Repubblica Ceca 7
IQ - Iraq 7
JM - Giamaica 7
PH - Filippine 7
SA - Arabia Saudita 7
CR - Costa Rica 6
EG - Egitto 6
GT - Guatemala 6
LT - Lituania 6
VE - Venezuela 6
MA - Marocco 5
PR - Porto Rico 5
TT - Trinidad e Tobago 5
AL - Albania 4
AT - Austria 4
IL - Israele 4
KG - Kirghizistan 4
TH - Thailandia 4
TW - Taiwan 4
HU - Ungheria 3
KE - Kenya 3
NG - Nigeria 3
NI - Nicaragua 3
PK - Pakistan 3
SV - El Salvador 3
TN - Tunisia 3
AZ - Azerbaigian 2
CH - Svizzera 2
EU - Europa 2
GP - Guadalupe 2
JO - Giordania 2
LV - Lettonia 2
MY - Malesia 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
BS - Bahamas 1
BY - Bielorussia 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
KW - Kuwait 1
KZ - Kazakistan 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SC - Seychelles 1
TG - Togo 1
Totale 21.690
Città #
Woodbridge 4.341
Wilmington 3.950
Houston 3.493
Ashburn 596
Singapore 542
Fairfield 437
Chandler 384
Ann Arbor 360
San Jose 257
Hong Kong 165
Jacksonville 165
Seattle 158
Dublin 157
Beijing 147
Council Bluffs 142
Cambridge 141
Santa Clara 124
Rome 122
Los Angeles 119
Medford 118
New York 112
Chicago 100
Dearborn 92
Buffalo 63
Salt Lake City 59
Lawrence 56
Hanoi 55
The Dalles 54
Ho Chi Minh City 47
Zhengzhou 41
Kraków 36
Tokyo 36
São Paulo 33
Moscow 32
Dallas 30
Lauterbourg 30
Mülheim 26
San Diego 25
Brussels 22
Jakarta 21
London 20
North Bergen 20
Helsinki 19
Phoenix 18
Elk Grove Village 16
Engelhard 16
Munich 16
Tampa 16
Atlanta 15
Milan 15
Denver 14
Orem 14
Menlo Park 13
San Mateo 13
Toronto 13
Warsaw 12
Brooklyn 11
Chennai 11
Frankfurt am Main 11
Da Nang 10
Norwalk 10
San Francisco 10
Sterling 10
Guangzhou 9
Montreal 9
Seoul 9
University Park 9
Boardman 8
Curitiba 8
Dulles 8
Falls Church 8
Nuremberg 8
Detroit 7
Lappeenranta 7
Miami 7
Nanjing 7
Newark 7
Olomouc 7
Poplar 7
Rio de Janeiro 7
Bologna 6
Cairo 6
Columbus 6
Johannesburg 6
Kissimmee 6
Lancaster 6
New Delhi 6
Nürnberg 6
Redondo Beach 6
Redwood City 6
Amsterdam 5
City of London 5
Haiphong 5
Kingston 5
Las Vegas 5
Manchester 5
Mexico City 5
Philadelphia 5
Shanghai 5
Steuben 5
Totale 17.453
Nome #
Placenta Growth Factor Expression Has Prognostic Value in Malignant Pleural Mesothelioma 605
Antimitotic and antiviral activities of Kelletinin A in HTLV-1 infected MT2 cells 548
Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo 536
Detection of cellular heterogeneity by DNA ploidy, 17 chromosome, and p53 gene in primary carcinoma and metastasis in a case of ovarian cancer 533
Placenta growth factor is a survival factor for human malignant mesothelioma cells 524
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients 514
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 512
Italian population data on the polymarker system and on the five short tandem repeat loci CSF1PO, TPOX, TH01, F13B, and vWA 499
HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia 496
Effects of polyphenols on oxidative stress-mediated injury in cardiomyocytes 496
Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice 490
The crossroads between cancer immunity and autoimmunity: antibodies to self antigens 474
The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis 473
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis 469
Role of inflammation and angiogenic growth factors in malignant mesothelioma 467
The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomas 463
Placenta growth factor expression has prognostic value in malignant pleural mesothelioma 463
Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin 456
Human T-lymphotropic retrovirus infection in Italy 452
A new retrovirus from cutaneous T-cell limphoma 450
The v-sis transforming gene of simian sarcoma virus is a new onc gene of primate origin. 447
High frequency of human papillomavirus detection in urinary bladder cancer 441
Post-transfusional human retrovirus infection in 41 Italian beta-thalassemic patients 441
Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function 441
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis. 434
Another mechanism involved in AIDS-KS progression. 431
Globin mRNA sequences in polyadenylated and nonpolyadenylated nuclear precursor-messenger RNA from avian erythroblasts. 425
Basic fibroblast growth factor modifies the interactions between endothelial cells/fibronectin: Implications for progression of AIDS- associated Kaposi's sarcoma 411
Abundant transcription of a cellular gene in T cells infected with human T-cell leukemia-lymphoma virus 409
Molecular diagnostic in human retroviruses pathology 408
Simultaneous detection of reverse transcriptase and high molecular weight RNA in tissue of patients with Hodgkin's disease and patients with leukemia. 406
The use of capillary electrophoresis in forensic DNA analysis 401
Transcription of placenta growth factor type-2 correlates with intratumoral microvessel density in breast carcinomas. 399
HTLV-I and HIV infection in drug addicts in Italy 397
Antimitotic and antiviral activities of Kelletinin A in HTLV-1 infected MT2 cells. 383
Human T-lymphotropic retroviruses: a new member of the family. 382
HTLV-I is endemic in southern Italy: detection of the first infectious cluster in a white population 376
null 345
Electrochemically reduced water delays mammary tumors growth in mice and inhibits breast cancer cells survival in vitro 342
The angiogenic properties of HIV-I Tat protein are mediated by two different domains. 336
Effects of a natural multi-component compound formulation on the growth, morphology and extracellular matrix production of human adult dermal fibroblasts 336
T-helper phenotype chronic lymphocytic leukaemia and "adult T-cell leukaemia" in Italy. Endemic HTLV-I-related T-cell leukaemias in southern Europe 319
The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor 317
Multifaceted Role of the Placental Growth Factor (PlGF) in the Antitumor Immune Response and Cancer Progression. 315
Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes? 285
Polyphenol-mediated autophagy in cancer: evidence of in vitro and in vivo studies 221
High sensitivity C-reactive protein increases the risk of carotid plaque instability in male dyslipidemic patients 215
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo 211
Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells 199
Targeting the tumor immune microenvironment with "nutraceuticals": from bench to clinical trials 194
3D printing decellularized extracellular matrix to design biomimetic scaffolds for skeletal muscle tissue engineering 168
Infection by high-risk human papillomaviruses, epithelial-to-mesenchymal transition and squamous pre-malignant or malignant lesions of the uterine cervix: a series of chained events? 166
Cardiac regeneration: the heart of the issue 164
PlGF immunological impact during pregnancy 153
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 152
Enhancement of neuroblastoma NK-cell-mediated lysis through NF-kB p65 subunit-induced expression of FAS and PVR, the loss of which is associated with poor patient outcome 149
The ETS Homologous Factor (EHF) Represents a Useful Immunohistochemical Marker for Predicting Prostate Cancer Metastasis. 145
Smart ECM-Based Electrospun Biomaterials for Skeletal Muscle Regeneration 98
PTX3: The ensemble biomarker of human diseases 76
SARS‐COV‐2 and infectivity: Possible increase in infectivity associated to integrin motif expression 18
Totale 21.876
Categoria #
all - tutte 51.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.163


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022530 0 0 0 0 17 70 43 38 67 54 55 186
2022/2023808 96 86 65 107 49 177 62 49 58 3 44 12
2023/2024319 40 10 15 5 15 79 14 3 7 55 16 60
2024/20252.065 65 425 172 71 52 109 88 86 150 95 557 195
2025/20262.307 165 124 306 188 234 55 340 244 240 244 92 75
2026/20271.081 98 123 439 412 9 0 0 0 0 0 0 0
Totale 21.876